Top Markets
Coin of the day
Caris Life Sciences, Inc. Caris Life Sciences, Inc.

Caris Life Sciences, Inc.

CAI
Classifica tra le azioni #2605
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing... Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
Prezzo delle azioni
$27.75
Capitalizzazione di mercato
$7.84B
Variazione (1 giorno)
6.21%
Variazione (1 anno)
-27.88%
Paese
US
Scambia Caris Life Sciences, Inc. (CAI)

Categoria

EPS per Caris Life Sciences, Inc. (CAI)
EPS al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Caris Life Sciences, Inc., l’EPS attuale della società (TTM) è 0. Alla fine del 2026, la società aveva un EPS di 0 uguale a rispetto a quello del 2026, che era di 0.
Storico EPS per Caris Life Sciences, Inc. da 2026 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
Non abbastanza dati per le date fornite.
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
$17.32 -
US
$27.74 -
NL
$-7.98 -
US
$-5.29 -
AU
- -
CH